← Back to Clinical Trials
Recruiting NCT07283003
NCT07283003 Evaluating Postoperative Pain After Ureterorenoscopy.
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT07283003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lukas J Hefermehl |
| Condition | Ureteral Stones |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-08 |
| Primary Completion | 2027-09 |
Trial Parameters
Condition Ureteral Stones
Sponsor Lukas J Hefermehl
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-01-08
Completion 2027-09
Interventions
No Double-J catheter insertionDouble-J catheter
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Comparison of routine postoperative stenting versus no stenting after ureterorenoscopy for ureteral stones to assess the necessity and impact on complication risk.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Patients with ureteral stones scheduled for ureteroscopy (URS) and stone removal * Previous pre-stenting * Informed Consent as documented Exclusion Criteria: * Complex ureteral conditions (e.g., known ureteral strictures) * Impacted stones * Solitary kidney * Patients with significant renal stones (\>3mm) * Previous ureteral surgeries (except endoscopic stone treatments) * Pregnancy or suspected pregnancy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology